Population genetic structure of variable drug response
Top Cited Papers
- 29 October 2001
- journal article
- Published by Springer Nature in Nature Genetics
- Vol. 29 (3) , 265-269
- https://doi.org/10.1038/ng761
Abstract
Geographic patterns of genetic variation, including variation at drug metabolizing enzyme (DME) loci and drug targets, indicate that geographic structuring of inter-individual variation in drug response may occur frequently. This raises two questions: how to represent human population genetic structure in the evaluation of drug safety and efficacy, and how to relate this structure to drug response. We address these by (i) inferring the genetic structure present in a heterogeneous sample and (ii) comparing the distribution of DME variants across the inferred genetic clusters of individuals. We find that commonly used ethnic labels are both insufficient and inaccurate representations of the inferred genetic clusters, and that drug-metabolizing profiles, defined by the distribution of DME variants, differ significantly among the clusters. We note, however, that the complexity of human demographic history means that there is no obvious natural clustering scheme, nor an obvious appropriate degree of resolution. Our comparison of drug-metabolizing profiles across the inferred clusters establishes a framework for assessing the appropriate level of resolution in relating genetic structure to drug response.Keywords
This publication has 18 references indexed in Scilit:
- Consistent Long-Range Linkage Disequilibrium Generated by Admixture in a Bantu-Semitic Hybrid PopulationAmerican Journal of Human Genetics, 2000
- A functional polymorphism of the cytochrome P450 1A2 (CYP1A2) gene: association with tardive dyskinesia in schizophreniaMolecular Psychiatry, 2000
- Optimization of cytochrome P4502D6 (CYP2D6) phenotype assignment using a genotyping algorithm based on allele frequency dataPharmacogenetics and Genomics, 1999
- Functional significance of a C→A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeineBritish Journal of Clinical Pharmacology, 1999
- 11. Gene–nutrient interactions in nutritional epidemiologyPublished by Oxford University Press (OUP) ,1997
- MOLECULAR MECHANISMS OF GENETIC POLYMORPHISMS OF DRUG METABOLISMAnnual Review of Pharmacology and Toxicology, 1997
- Nomenclature for human CYP2D6 allelesPharmacogenetics, 1996
- [23] Genetic tests which identify the principal defects in CYP2C19 responsible for the polymorphism in mephenytoin metabolismPublished by Elsevier ,1996
- Molecular mechanism of slow acetylation of drugs and carcinogens in humans.Proceedings of the National Academy of Sciences, 1991
- Identification of the primary gene defect at the cytochrome P450 CYP2D locusNature, 1990